Mydecine Innovations Group Inc (CSE: MYCO) (OTC: MYCOF) (FSE: 0NF), a Canada-based life sciences company, has named former Red Bull marketing executive, Jim Gunning, as its new chief marketing officer, it was reported on Friday.
Gunning has over two decades of experience in marketing. He has served as the managing director of RESQWATER and as a consultant for Blue Sky Biologicals.
In the new role, Gunning will be responsible for helping Mydecine to become a household name, and for developing a marketing campaign around the company's new fungtional mushroom product range under Mydecine Health Sciences, the company's operational branch. The fungtional mushroom product line should be on retail shelves across the US before the end of this year.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business